Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2452

1.

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

[No authors listed]

Arch Intern Med. 1994 Jul 11;154(13):1449-57. Erratum in: Arch Intern Med 1994 Oct 10;154(19):2254.

PMID:
8018000
4.
5.

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

Hart RG, Benavente O, McBride R, Pearce LA.

Ann Intern Med. 1999 Oct 5;131(7):492-501.

6.

[Atrial fibrillation and apoplexy--risks and prevention].

Koefoed BG, Gulløv AL, Petersen P.

Nord Med. 1996 Jun;111(6):171-5. Danish.

PMID:
8700641
7.

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.

8.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
9.

Atrial fibrillation and stroke. Three new studies, three remaining questions.

Albers GW.

Arch Intern Med. 1994 Jul 11;154(13):1443-8. Review.

PMID:
8017999
10.

Guidelines for stroke prevention in patients with atrial fibrillation.

Howard PA.

Drugs. 1999 Dec;58(6):997-1009. Review.

PMID:
10651387
12.

[Atrial fibrillation and thromboembolic events prevention. State of the art].

Matteoli S, Trappolini M, Chillotti FM.

Minerva Cardioangiol. 2001 Feb;49(1):1-13. Review. Italian.

PMID:
11279381
13.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
14.
15.

Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.

Caro JJ, Flegel KM, Orejuela ME, Kelley HE, Speckman JL, Migliaccio-Walle K.

CMAJ. 1999 Sep 7;161(5):493-7. Erratum in: CMAJ 2000 Apr 4;162(7):973.

16.

Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?

Gottlieb LK, Salem-Schatz S.

Arch Intern Med. 1994 Sep 12;154(17):1945-53. Review.

PMID:
8074598
17.

Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.

Albers GW, Yim JM, Belew KM, Bittar N, Hattemer CR, Phillips BG, Kemp S, Hall EA, Morton DJ, Vlasses PH.

Arch Intern Med. 1996 Nov 11;156(20):2311-6.

PMID:
8911237
18.

Prevention of stroke in patients with nonvalvular atrial fibrillation.

Hart RG, Sherman DG, Easton JD, Cairns JA.

Neurology. 1998 Sep;51(3):674-81. Review.

PMID:
9748009
19.

Lessons from the Stroke Prevention in Atrial Fibrillation trials.

Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, Nasco E, Sherman DG, Talbert RL, Marler JR; Stroke Prevention in Atrial Fibrillation Investigators.

Ann Intern Med. 2003 May 20;138(10):831-8. Review.

PMID:
12755555
20.

Atrial fibrillation, anticoagulation, and stroke.

Morley J, Marinchak R, Rials SJ, Kowey P.

Am J Cardiol. 1996 Jan 25;77(3):38A-44A. Review.

PMID:
8607390

Supplemental Content

Support Center